[Federal Register Volume 76, Number 128 (Tuesday, July 5, 2011)]
[Notices]
[Page 39127]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-16791]



[[Page 39127]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 16, 2011, Cayman Chemical 
Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
N-Ethylamphetamine (1475)...................  I
N-N-Dimethylamphetamine (1480)..............  I
Aminorex (1585).............................  I
4-Methylaminorex (cis isomer) (1590)........  I
1-Pentyl-3-(1-naphthoyl)indole (7118).......  I
1-Butyl-3-(1-naphthoyl)indole (7173)........  I
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)    I
 Indole (7200).
Alpha-ethyltryptamine (7249)................  I
5-(1,1-Dimethulheptyl)-2-[(1R,3S)-3-          I
 hydroxycyclohexyl]-phenol (7297).
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-           I
 hydroxycyclohexyl]-phenol (7298).
Lysergic acid diethylamide (7315)...........  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine  I
 (7348).
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
3,4,5-Trimethoxyamphetamine (7390)..........  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
2,5-Dimethoxy-4-ethylamphetamine (7399).....  I
3,4-Methylenedioxyamphetamine (7400)........  I
5-Methoxy-3,4-methylenedioxyamphetamine       I
 (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine       I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
5-Methoxy-N-N-dimethyltryptamine (7431).....  I
Alpha-methyltryptamine (7432)...............  I
Diethyltryptamine (7434)....................  I
Dimethyltryptamine (7435)...................  I
5-Methoxy-N,N-diisopropyltryptamine (7439)..  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Lisdexamfetamine (1205).....................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of marihuana 
derivatives for research purposes. In reference to drug code 7360 
(Marihuana), the company plans to bulk manufacture cannabidol. In 
reference to drug code 7370 (Tetrahydrocannabinols), the company will 
manufacture a synthetic THC. No other activity for this drug code is 
authorized for this registration.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than September 6, 2011.

    Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.

[FR Doc. 2011-16791 Filed 7-1-11; 8:45 am]
BILLING CODE 4410-09-P